124 related articles for article (PubMed ID: 35354463)
1. Diagnosis of advanced cervical cancer, missed opportunities?
Mattern J; Letendre I; Sibiude J; Pénager C; Jnifen A; Souare F; Ayel S; Nguyen T; Mandelbrot L
BMC Womens Health; 2022 Mar; 22(1):97. PubMed ID: 35354463
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
4. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
5. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
6. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
[TBL] [Abstract][Full Text] [Related]
7. Pap tests in the diagnosis of cervical cancer: Help or hinder?
Philp L; Jembere N; Wang L; Gao J; Maguire B; Kupets R
Gynecol Oncol; 2018 Jul; 150(1):61-66. PubMed ID: 29773301
[TBL] [Abstract][Full Text] [Related]
8. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
9. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
10. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
11. Secondary cervical cancer prevention in routine prenatal care - coverage, results and lessons for the future.
Kuczborska K; Kacperczyk-Bartnik J; Wolska M; Pluta M; Bartnik P; Dobrowolska-Redo A; Romejko-Wolniewicz E
Ginekol Pol; 2019; 90(7):396-402. PubMed ID: 31392709
[TBL] [Abstract][Full Text] [Related]
12. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
13. [Cytological history of 148 women presenting with invasive cervical cancer].
Mubiayi N; Bogaert E; Boman F; Leblanc E; Vinatier D; Leroy JL; Querleu D
Gynecol Obstet Fertil; 2002 Mar; 30(3):210-7. PubMed ID: 11998209
[TBL] [Abstract][Full Text] [Related]
14. Compliance with Papanicolaou smear screening following tubal ligation in women with cervical cancer.
Winkler HA; Anderson PS; Fields AL; Runowicz CD; DeVictoria C; Goldberg GL
J Womens Health; 1999; 8(1):103-7. PubMed ID: 10094087
[TBL] [Abstract][Full Text] [Related]
15. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
[No Abstract] [Full Text] [Related]
16. The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist?
Kenter GG; Schoonderwald EM; Koelma IA; Arentz N; Hermans J; Fleuren GJ
Acta Obstet Gynecol Scand; 1996 Apr; 75(4):400-3. PubMed ID: 8638464
[TBL] [Abstract][Full Text] [Related]
17. [Cervical cancer in Mecklenburg-Western Pomerania. Tumor stage, histological tumor type, age and screening participation of 985 patients].
Marquardt K; Stubbe M; Broschewitz U
Pathologe; 2016 Feb; 37(1):78-83. PubMed ID: 26660458
[TBL] [Abstract][Full Text] [Related]
18. Support for down-staging of pregnancy-associated cervical cancer.
Kärrberg C; Rådberg T; Holmberg E; Norström A
Acta Obstet Gynecol Scand; 2015 Jun; 94(6):654-9. PubMed ID: 25845736
[TBL] [Abstract][Full Text] [Related]
19. A retrospective review of cervical cytology in women developing invasive squamous cell carcinoma.
Walker EM; Hare MJ; Cooper P
Br J Obstet Gynaecol; 1983 Nov; 90(11):1087-91. PubMed ID: 6639901
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
